ILD
Granulomatosis with Polyangiitis
search
Granulomatosis with Polyangiitis
, Wegener's Granulomatosis
See Also
Interstitial Lung Disease
Small Vessel Vasculitis
Glomerulonephritis
Epidemiology
Rare
Incidence
Peak
Incidence
during fourth decade of life
Pathophysiology
Renamed in 2012 as Granulomatosis with Polyangiitis
Previously known as Wegener's Granulomatosis
Classic Triad of Involvement
Interstitial Lung Disease
Glomerulonephritis
Upper respiratory tract (Sinus and nasal disease)
Granuloma
tous
ANCA
-Associated
Small Vessel Vasculitis
Necrotizing
Granuloma
s
Symptoms
Paranasal Sinus
congestion
Sinus pain
Rhinorrhea
Purulent
Nasal Discharge
Epistaxis
Respiratory
Cough
Hemoptysis
Dyspnea
Signs
Head and neck changes
Nasal mucosa ulceration
Septal perforation
Cartilaginous destruction (Saddle nose deformity)
Gingiva
l ulceration
Recurrent
Sinusitis
Otitis Media
Hearing Loss
Lung
Changes
See
Interstitial Lung Disease
Pneumonia
Renal
See
Glomerulonephritis
Eye Involvement may also occur
Conjunctivitis
Uveitis
Retinitis
Chemosis
Exophthalmos
Rheumatologic
Polyarthritis
Neurologic
Neuropathy
Differential Diagnosis
See
Interstitial Lung Disease
See
ANCA
-Associated
Small Vessel Vasculitis
Polyarteritis Nodosa
Labs
Antineutrophil Cytoplasmic Antibodies
(
ANCA
)
cANCA positive in 75-90% of patients
pANCA positive in 20% of cases
ANCA
Test Specificity
: 98%
Despite
Specificity
, high
False Positive Rate
due to rare
Incidence
of condition
Indications for
ANCA
testing (do not obtain solely due to recurrent
Sinusitis
)
Pulmonary-Renal Syndrome
Rapidly progressive
Renal Failure
Mononeuritis multiplex
Pulmonary Hemorrhage
Complete Blood Count
Anemia
Leukocytosis
Eosinophilia
Urinalysis
Consistent with
Glomerulonephritis
Hyperglobulinemia
Imaging
Chest XRay
See
Interstitial Lung Disease
Bronchopneumonic patches
Multiple nodular densities (may cavitate)
Diagnostics
Open lung biopsy (most definitive)
Renal and sinus biopsy are often non-diagnostic
Management
Induction Therapy
Cyclophosphamide
(
Cytoxan
)
Corticosteroid
s
Consider high-dose IV
Methylprednisolone
for 3 days
Maintenance Therapy
Taper
Prednisone
Maintain
Cyclophosphamide
for 12 to 18 months
Coarse
Mortality often associated with
Renal Failure
References
Allen in Goldman (2000) Cecil Medicine, p. 1529-32
Calabrese in Ruddy (2001) Kelley's Rheum, p. 1167-76
Ali (2018) Am Fam Physician 98(3): 164-70 [PubMed]
Type your search phrase here